 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.99.1.3
- Dna topoisomerase (ATP-hydrolyzing).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP-dependent breakage, passage and rejoining of double-stranded DNA.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
chromosome
|
1 term
|
 |
|
Biological process
|
DNA topological change
|
1 term
|
 |
|
Biochemical function
|
DNA binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:18947-18953
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
An open conformation of the Thermus thermophilus gyrase B ATP-binding domain.
|
|
V.Lamour,
L.Hoermann,
J.M.Jeltsch,
P.Oudet,
D.Moras.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
DNA gyrase forms an A(2)B(2) tetramer involved in DNA replication, repair,
recombination, and transcription in which the B subunit catalyzes ATP
hydrolysis. The Thermus thermophilus and Escherichia coli gyrases are homologues
and present the same catalytic activity. When compared with that of the E. coli
43K-5'-adenylyl-beta,gamma-imidodiphosphate complex, the crystal structure of
Gyrase B 43K ATPase domain in complex with novobiocin, one of the most potent
inhibitors of gyrase shows large conformational changes of the subdomains within
the dimer. The stabilization of loop 98-118 closing the active site through
dimeric contacts and interaction with domain 2 allows to observe
novobiocin-protein interactions that could not be seen in the 24K-inhibitor
complexes. Furthermore, this loop adopts a position which defines an
"open" conformation of the active site in absence of ATP, in contrast
with the "closed" conformation adopted upon ATP binding. All together,
these results indicate how the subdomains may propagate conformational changes
from the active site and provide crucial information for the design of more
specific inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Fig. 5. Novobiocin binding. The novobiocin molecule (in
blue) lies at the entry of the ATP-binding site with electronic
density (final map 2F[o] F[c], 1.3
) shown in
orange. Most of the contacts with the pocket are the same as the
ones previously observed with the 24K domain. Due to the dimer
formation and the resulting stabilization of loop 98-118 (shown
in red), additional residues (in yellow) contribute to the
hydrophobic region of the pocket, among them is Ile^10 from the
N-terminal arm of the other monomer (in purple). There is also
one additional strong H-bond with Asp80 (a Gly in E. coli)
upstream loop 83-89 (in green).
|
 |
Figure 6.
Fig. 6. Open and closed conformation of the active site.
In the closed conformation (in yellow), the loop 98-118 is
tightened around the ATP molecule (ADPPNP in red) which -phosphate
is contacted by domain 2 residues Lys337 and Gln335. Lys102
(E.c. 103) and Lys109 (E.c. 110) implicated in the catalysis as
well as Tyr108 (E.c. 109) binding the ATP adenine ring undergo
large movement (respectively, blue and red arrows) in the
absence of ATP. The novobiocin molecule (in sky blue) blocks the
open conformation of the active site (in blue) which might be
one conformation of the active site after ATP hydrolysis. E.c.,
E. coli.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
18947-18953)
copyright 2002.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Saíz-Urra,
M...Cabrera Pérez,
A.M.Helguera,
and
M.Froeyen
(2011).
Combining molecular docking and QSAR studies for modelling the antigyrase activity of cyclothialidine derivatives.
|
| |
Eur J Med Chem, 46,
2736-2747.
|
 |
|
|
|
|
 |
C.Sissi,
and
M.Palumbo
(2010).
In front of and behind the replication fork: bacterial type IIA topoisomerases.
|
| |
Cell Mol Life Sci, 67,
2001-2024.
|
 |
|
|
|
|
 |
I.Gómez García,
C.E.Stevenson,
I.Usón,
C.L.Freel Meyers,
C.T.Walsh,
and
D.M.Lawson
(2010).
The crystal structure of the novobiocin biosynthetic enzyme NovP: the first representative structure for the TylF O-methyltransferase superfamily.
|
| |
J Mol Biol, 395,
390-407.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Xie
(2010).
Dynamics of strand passage catalyzed by topoisomerase II.
|
| |
Eur Biophys J, 39,
1251-1259.
|
 |
|
|
|
|
 |
M.J.Edwards,
R.H.Flatman,
L.A.Mitchenall,
C.E.Stevenson,
T.B.Le,
T.A.Clarke,
A.R.McKay,
H.P.Fiedler,
M.J.Buttner,
D.M.Lawson,
and
A.Maxwell
(2009).
A crystal structure of the bifunctional antibiotic simocyclinone d8, bound to DNA gyrase.
|
| |
Science, 326,
1415-1418.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.J.Schoeffler,
and
J.M.Berger
(2008).
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.
|
| |
Q Rev Biophys, 41,
41.
|
 |
|
|
|
|
 |
F.Mueller-Planitz,
and
D.Herschlag
(2008).
Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism.
|
| |
J Biol Chem, 283,
17463-17476.
|
 |
|
|
|
|
 |
N.D.Thomsen,
and
J.M.Berger
(2008).
Structural frameworks for considering microbial protein- and nucleic acid-dependent motor ATPases.
|
| |
Mol Microbiol, 69,
1071-1090.
|
 |
|
|
|
|
 |
D.A.Ostrov,
J.A.Hernández Prada,
P.E.Corsino,
K.A.Finton,
N.Le,
and
T.C.Rowe
(2007).
Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
|
| |
Antimicrob Agents Chemother, 51,
3688-3698.
|
 |
|
|
|
|
 |
K.D.Corbett,
P.Benedetti,
and
J.M.Berger
(2007).
Holoenzyme assembly and ATP-mediated conformational dynamics of topoisomerase VI.
|
| |
Nat Struct Mol Biol, 14,
611-619.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2006).
Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol.
|
| |
Nucleic Acids Res, 34,
4269-4277.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Sobolevsky,
and
E.N.Trifonov
(2006).
Protein modules conserved since LUCA.
|
| |
J Mol Evol, 63,
622-634.
|
 |
|
|
|
|
 |
Y.Y.Huang,
J.Y.Deng,
J.Gu,
Z.P.Zhang,
A.Maxwell,
L.J.Bi,
Y.Y.Chen,
Y.F.Zhou,
Z.N.Yu,
and
X.E.Zhang
(2006).
The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
|
| |
Nucleic Acids Res, 34,
5650-5659.
|
 |
|
|
|
|
 |
D.Gadelle,
C.Bocs,
M.Graille,
and
P.Forterre
(2005).
Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.
|
| |
Nucleic Acids Res, 33,
2310-2317.
|
 |
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2005).
Structural dissection of ATP turnover in the prototypical GHL ATPase TopoVI.
|
| |
Structure, 13,
873-882.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Dupont,
A.Aubry,
E.Cambau,
and
L.Gutmann
(2005).
Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniae.
|
| |
J Bacteriol, 187,
1536-1540.
|
 |
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2004).
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
|
| |
Annu Rev Biophys Biomol Struct, 33,
95.
|
 |
|
|
|
|
 |
S.Bellon,
J.D.Parsons,
Y.Wei,
K.Hayakawa,
L.L.Swenson,
P.S.Charifson,
J.A.Lippke,
R.Aldape,
and
C.H.Gross
(2004).
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.
|
| |
Antimicrob Agents Chemother, 48,
1856-1864.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Sifaoui,
V.Lamour,
E.Varon,
D.Moras,
and
L.Gutmann
(2003).
ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.
|
| |
J Bacteriol, 185,
6137-6146.
|
 |
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2003).
Structure of the topoisomerase VI-B subunit: implications for type II topoisomerase mechanism and evolution.
|
| |
EMBO J, 22,
151-163.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Classen,
S.Olland,
and
J.M.Berger
(2003).
Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.
|
| |
Proc Natl Acad Sci U S A, 100,
10629-10634.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Lamour,
L.Hoermann,
J.M.Jeltsch,
P.Oudet,
and
D.Moras
(2002).
Crystallization of the 43 kDa ATPase domain of Thermus thermophilus gyrase B in complex with novobiocin.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
1376-1378.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|